834 filings
Page 7 of 42
8-K
BPMC
Blueprint Medicines Corp
27 Feb 23
Regulation FD Disclosure
8:55am
8-K
BPMC
Blueprint Medicines Corp
23 Feb 23
Termination of a Material Definitive Agreement
4:06pm
S-8
BPMC
Blueprint Medicines Corp
17 Feb 23
Registration of securities for employees
8:12am
424B5
BPMC
Blueprint Medicines Corp
17 Feb 23
Prospectus supplement for primary offering
8:06am
S-3ASR
BPMC
Blueprint Medicines Corp
17 Feb 23
Automatic shelf registration
7:37am
10-K
2022 FY
BPMC
Blueprint Medicines Corp
Annual report
16 Feb 23
5:24pm
8-K
BPMC
Blueprint Medicines Corp
16 Feb 23
Blueprint Medicines Reports Fourth Quarter and Full Year 2022 Results
8:21am
SC 13G/A
BPMC
Blueprint Medicines Corp
14 Feb 23
Blueprint Medicines / PRICE T ROWE ASSOCIATES ownership change
12:38pm
8-K
BPMC
Blueprint Medicines Corp
10 Feb 23
Blueprint Medicines Announces Partial Clinical Hold for Phase 1/2 VELA Trial of BLU-222
8:26am
SC 13G/A
BPMC
Blueprint Medicines Corp
9 Feb 23
Blueprint Medicines / VANGUARD ownership change
11:12am
SC 13G/A
BPMC
Blueprint Medicines Corp
9 Feb 23
Blueprint Medicines / FMR ownership change
8:23am
SC 13G/A
Wellington Management Group LLP
6 Feb 23
Blueprint Medicines / WELLINGTON MANAGEMENT ownership change
2:49pm
SC 13G/A
BPMC
Blueprint Medicines Corp
26 Jan 23
Blueprint Medicines / BlackRock ownership change
8:52am
SC 13G/A
BPMC
Blueprint Medicines Corp
20 Jan 23
Blueprint Medicines / BlackRock ownership change
9:43am
4
John Tsai
9 Jan 23
Blueprint Medicines / John Tsai ownership change
5:16pm
3
John Tsai
9 Jan 23
Blueprint Medicines / John Tsai ownership change
5:13pm
8-K
BPMC
Blueprint Medicines Corp
9 Jan 23
Regulation FD Disclosure
8:30am
8-K
BPMC
Blueprint Medicines Corp
6 Jan 23
Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors
4:33pm
8-K
BPMC
Blueprint Medicines Corp
27 Dec 22
Departure of Directors or Certain Officers
4:27pm
4
Jeffrey W. Albers
7 Dec 22
Blueprint Medicines / Jeffrey W. Albers ownership change
8:52pm